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Abstract 
Purpose: To explore the knowledge, attitudes, practice and perceived barriers of community 
pharmacists regarding provision of pharmaceutical care as well as provide recommendations on how to 
advance the service during the early stage of development in Macao.  
Methods: A questionnaire comprising 10 items was used to collect respondents’ demographic 
information and to evaluate their understanding of pharmaceutical care, attitude towards service 
provision, current practice and perceived barriers. Descriptive and comparative analysis of the results 
was conducted. 
Results: While 95 % of the participating pharmacists agreed that patients’ health was their primary 
responsibility, only 57 % believed that they can provide better pharmaceutical care in the future. The 
majority spent most of their work time counselling patients (90 %) and checking prescription (70 %). 
Only a small portion monitored adverse drug reaction and drug compliance (44 %), engaged in health 
screening or drug safety promotion (20 %) or maintained patient medication records (4 %). Insufficient 
communication with physicians (90 %), lack of time (79 %) and lack of physical space at the pharmacy 
(76 %) were considered the most significant barriers. 
Conclusion: A suboptimal level of pharmaceutical care is provided by pharmacists in Macao. 
Considering the barriers identified and integrating other country experiences, establishing an enabling 
atmosphere using policy and regulatory measures is the fundamental element for advancing 
pharmaceutical care by community pharmacists. 
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Rational use of medicines can help increase 
longevity and quality of life for individuals. 
However, medication use without due care 
especially among the chronically-ill, aging 
population is associated with suboptimal clinical 
outcomes and increased risks of drug-related 
problems (DRPs), resulting in preventable 
personal suffering and costly health 
expenditures. Pharmaceutical care provided by 
pharmacists is considered as one of the key 
practice to alleviate the risks of DRPs [1,2]. In 
1990, Hepler and Strand formulated the concept 
of pharmaceutical care , defining it as “the 
responsible provision of drug therapy for the 
purpose of achieving definite outcomes which 
improve a patient’s quality of life” [3]. This vision 
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was shared by many countries and professional 
groups around the world as a milestone for 
professional development. More and more 
pharmacists have become increasingly patient-
focused and proactive in acting responsibly to 
optimize clinical outcome of pharmacotherapy 
and to minimize associated risks. In the US, 
European countries, Canada and New Zealand, 
pharmaceutical care has been well integrated 
into most pharmacists’ routine practice [4-6]. 
Benefits of pharmaceutical care have been fully 
demonstrated in terms of clinical outcome and 
many other aspects such as patients’ 
compliance, health literary and disease 
screening [7-14]. 
 
Depending on the legal, political and health care 
systems, different forms and levels of 
pharmaceutical care development and adoption 
have been observed across countries [8]. In 
pursuit of continuous advancement, research 
efforts have been made to identify possible 
barriers hindering the development of this 
professional service. Similar set of barriers have 
been found in many countries, the significance of 
each barrier varied greatly, which warrants 
approach and policy specific to the national 
situation. For instance in the US, lack of 
reimbursement system was considered the most 
important barrier [15,16] whereas in Iran and 
Pakistan, ambiguity about the professional role of 
pharmacists and the concept of pharmaceutical 
care were found to limit the development of 
pharmaceutical care service [17,18]. 
 
Despite increasing concerns over DRPs, the 
extent of pharmaceutical care provision and 
possible barriers in Macao has never been 
examined before. The objectives of this study 
were to examine the pharmacists’ level of 
understanding of pharmaceutical care, their 
attitude towards and current practice of the 
service, and the perceived barriers. It is 
anticipated that the study will put forward 
recommendations on how to advance the service 
in areas where pharmaceutical care is only at the 






The conceptual framework used to design this 
questionnaire was based on the pharmaceutical 
care model found in the literature [3]. A similar 
study [19] was also consulted and special 
elements unique to the business environment of 
community pharmacies in Macao considered 





Macao has a population of 600,000 and was 
used as the study target. It is a small city where 
East meets West in almost every aspect 
including pharmacy practice. Pharmacy practice 
in the city has undergone dramatic changes 
since its reversion to China in 1999. The number 
of community pharmacies increased from 46 in 
2003 to 193 in 2013 and the number of 
registered pharmacists increased from 89 to 381 
during the same period of time. The legal 
responsibilities of registered pharmacists still 
confined to dispensing, medicine storing and 
providing, and quality and bio-chemical analysis 
of drug products. However, concerns over DRPs 
are increasing due to aging population, over-use 
of medications, poly-doctor, self-medications, 





The study was conducted in community 
pharmacies in Macao from January to February 
2014. Personal visit by researchers at randomly-
selected community pharmacies was used to 
distribute and retrieve self-administered 





The questionnaire was developed originally in 
English. Considering that Chinese would be the 
first language of most respondents, the 
questionnaire was translated into Chinese by the 
authors. The English content was kept for 
respondents’ reference to original expressions of 
the questions. A pre-test of the questionnaire 
was carried out with the participation of 5 
community pharmacists to assess the 
appropriateness of wordings and format of the 
questionnaire. Minor modifications were made 
based on their comments to achieve the final 
version of the questionnaire. 
 
The questionnaire consisted of five sections. The 
first section collected demographic data of the 
respondents such as gender, age, type of 
pharmacy they were practising, number of years 
of working experiences in pharmacy, highest 
pharmacy-related qualification, and prescription 
volume. In the second section, pharmacists were 
questioned about six statements regarding the 
concept, purpose and procedures of 
pharmaceutical care, and the role of pharmacists 
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on this matter. A 5-point Likert scale was 
adopted as the statement rating system ranging 
from 1 – not at all to 5 = very much. The third 
section consisted of 7 questions about 
pharmacists ’attitudes to pharmaceutical care. 
The fourth section asked about the frequency of 
the nine pharmaceutical care activities 
pharmacists performed during their daily practice 
using the scale 1 = never through 5 = always. 
These activities included DRP identification, DRP 
solving, follow-up evaluation, documentation in 
practice, health education, etc. In the last 
section, there were 11 questions regarding the 
barriers to the provision of pharmaceutical care 
in Macao. These barriers included lack of time, 
inadequate communication with doctors, lack of 
supportive policies, etc. In the third and last 
section, the 5-point Likert scale was used again 
by the pharmacists to express the level of 
agreement to the statements regarding their 
perceptions and barriers, where 1 = strongly 




SPSS 20.0 was used for data analysis. In the 
first section, the demographic data of the 
respondents were analysed using descriptive 
statistics. For the core of this study, which is 
sections 2 to 5, in addition to descriptive 
statistics, means was also used to determine the 
overall response of the respondents. Reliability of 
the scale used was tested using Cronbach’s 
alpha (minimum 0.5, ideally between 0.7 - 0.8). 
In addition, ANOVA was used to perform 
integrative analysis of the demographic data of 
the respondents collected in section 1 and the 
data collected in the core part of study to infer 
any association between the background of the 
pharmacists and their perceptions about 
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Of the total of 107 questionnaires sent out in the 
survey, 102 responses were received giving a 
response rate of 95.3 %. Among the received 
responses, two of them were not completed and 
were thus excluded. 100 responses were 
included in data analysis, giving a final response 
rate of 93.5 %. Demographic data of the 
respondents are listed in Table 1. The majority of 
the respondents were female (61 %), aged 
between 21 - 30 years (84 %), worked in chain 
pharmacies (more than 4 stores owned by the 
same organization) (73 %), had only worked for 
< 5 years compared to > 10 years (9 %), and 
held a bachelor degree as the highest pharmacy-
related qualification. In other words, most of the 
community pharmacists in Macao were new 
female graduates and work in chain pharmacies 
with limited practice experiences.  
 
The proportions of workload related to 
prescription medicines were found to be “less 
than 10 %” for 42 % of respondents, “11 - 20 %” 
for 14 % of respondents, “21 - 40 %” for 13 % of 
respondents, “41 - 50 %” for 9 % of respondents 
and “ more than 50 %” for 22 % of respondents.  
This data indicated a two-end distribution of job 
responsibility of prescription medicines. The low 
workload proportion in handling prescription 
medicines partly reflected the fact that many 
pharmacies in Macao served tourists mainly, 
which applied to the majority of the respondents 
’workplace. For the pharmacists who were able 
to dedicate 50 % workload to prescription 
medicines, the pharmacies were considered as 
prescription medicines oriented which usually 
participated in the government medicine-
subsidizing scheme. This represented 22 % of 
the respondents’ workplace. All the other 
pharmacies where the respondents worked were 
considered as neighbouring pharmacies. 
 
Pharmacists’ understanding of 
pharmaceutical care 
 
Table 2 shows the respondents’ understanding of 
the concept of pharmaceutical care. Although 
respondents’ understanding of the purpose of 
use of pharmaceutical care was satisfactory as 
shown in their responses to statements 2 and 4, 
their comprehension of the key attitude which is 
the responsible provision of pharmaceutical care 
was only acceptable with only 70 % respondent 
agreeing to Statement 1. The confusion about 
their roles in pharmaceutical care was further 
indicated as only 58 % respondents believed that 
all patients taking medicines require pharmacists’ 
help. Statements 3 and 6 were the two false 
items to test the respondents ’replies. Table 2 
also shows that the respondents had higher 
agreement on Statement 2 (Mean = 4.39), and 
Statement 4 (Mean = 4.09). Cronbach’s alpha 
over the 6 statements was 0.509. 
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  Table 1: Demographic profile of the respondents (N = 100) 
 
Variable % 
Sex Male 39 
Female 61 




Type of Pharmacy Chain pharmacy 70 
Independent pharmacy 30 










Proportion of workload 








Table 2: Pharmacists’ understanding of pharmaceutical care (N = 100) 
 




1. Pharmaceutical care is the responsible provision of drug 
therapy 
70% 3.74 
2. The aim of pharmaceutical are is to ensure the safety, 
efficacy, economy and rational use of medicines 
97% 4.39 
3. Pharmaceutical care is just a medication counselling service 12% 2.34 
4. Pharmaceutical care provides a feedback to optimize drug 
use 
90% 4.09 
5. All patients taking medicines require pharmacists ’help 58% 3.56 




Pharmacists’ attitudes to pharmaceutical care 
 
Table 3 illustrates the results of respondents 
’attitudes to pharmaceutical care. The 
respondents generally had a positive attitude and 
good determination to the provision of 
pharmaceutical care, 95 % of them agreed that 
patients’ health was their primary responsibility 
and would try their best to provide patients with 
the most suitable medicine as shown in their 
responses to statements 1 and 2. The results of 
statements 5 and 7 also indicated that 89 % of 
them were willing to provide the service and 98 
% acknowledged the expectations of the 
patients. 79 % of them were already conscious 
about the economy factor when choosing 
suitable medicines for their patients and 87 % 
considered the provision of quality 
pharmaceutical care a source of job satisfaction 
as shown by the responses to statements 3 and 
6. However, only 57 % of the respondents 
believed that they could provide more 
comprehensive pharmaceutical care in the 
future. Table 3 also shows that the respondents 
had the highest agreement on Statement 2 
(Mean = 4.42). Comparatively, they showed the 
lowest agreement on Statement 4 (Mean = 3.74). 
Cronbach’s alpha over the 7 statements was 
0.763. 
 
Perceived frequency of pharmaceutical care 
provision 
 
Table 4 lists the results of respondents 
’perceived frequency of pharmaceutical care 
provision in their daily practice. 85-90 % of the 
respondents spent considerable amount of time 
counselling with patients, instructing them about 
drug administration, dosage, and precautions, 
and providing general health information and 
medication information. Around 70 % of the 
respondents reported that they spent some of the 
time or most of their time performing prescription 
checks and conducting health education. Only 44 
% of the respondents monitored adverse drug 
reaction and drug compliance among patients as 
part of their usual practice. Less than 20 % of the 
respondents engaged in health screening 
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activities or drug safety promotion outside 
community pharmacy setting. Only 4 % of the 
respondents created personal medication record. 
As shown in Table 4, the respondents had the 
highest agreement on Statement 1 (Mean = 
4.16) and Statement 3 (Mean = 4.16). 
Comparatively, they expressed the much lower 
agreement on Statement 6 (Mean = 1.41), 
Statement 5 (Mean = 1.94), and Statement 9 
(Mean = 1.99). Cronbach’s alpha over the 9 
statements was 0.744. 
 
Perceived barriers to the provision of 
pharmaceutical care 
 
Table 5 lists the respondents’ opinions on the 
possible factors that might have inhibited the 
provision of pharmaceutical care. Over 90 % of 
the respondents agreed or strongly agreed that 
insufficient communication with physician was a 
barrier. 79 % of the respondents expressed that 
lack of physical space for pharmaceutical care 
provision was the second factor. Lack of time to 
provide pharmaceutical care (76 %), lack of 
patient acceptance of pharmaceutical care (71 
%), lack of compensation for pharmaceutical 
care provision (68 %), slow introduction of 
pharmacist law (66 %), and lack of face-to-face 
communication with patient (55 %) were also 
considered important factors by the respondents. 
However, less than 40 % of the respondents 
thought that lack of support to pharmaceutical 
care from pharmacy owners (37 %), lack of 
effective communication skills (36 %), lack of 
support to pharmaceutical care from other health 
care professionals (33 %) and lack of knowledge 
about drug use (29 %) were highly relevant 
barriers. Table 5 also shows that the 
respondents had the highest agreement on 
Statement 9 (Mean = 4.31) but the lowest 
agreement on Statement 7 (Mean = 2.72). 
 
In the ANOVA analysis, no significant findings 
indicating that there is no association between 
the background of the pharmacists and their 




Table 3: Pharmacists’ attitudes to pharmaceutical care (N=100) 
 




1. I think that maintaining patients ’health is my primary 
responsibility 
95 4.29 
2. I try my best to provide patients with suitable medicines. 95 4.42 
3. I consider patients ’economic situation in the process of 
pharmaceutical care provision. 
79 3.95 
4. I can provide more comprehensive pharmaceutical care than 
what is provided now 
57 3.74 
5. I would like to provide pharmaceutical care but lack basic 
working conditions 
89 4.00 
6. Providing pharmaceutical care offers me job satisfaction 87 4.27 




Table 4: Perceived frequency of pharmaceutical care provision (N = 100) 
 
Statement Some of the 
time and most 
of the time (%) 
Mean 
score 
1. Communicate with patients or customers in the counselling 
area 
90% 4.16 
2. Perform prescription check 73% 3.94 
3. Provide patients with direction for drug administration, 
dosage, and precautions 
89% 4.16 
4. Monitor adverse drug reaction and drug compliance among 
patients 
44% 3.03 
5. Engage in health screening activities, such as blood pressure 
measurement 
17% 1.94 
6. Create personal medication record e.g. electronic health 
record 
4% 1.41 
7. Conduct health education for patients 70% 3.53 
8. Provide general health information and medication information 
to patients 
85% 4.08 
9. Promote drug safety knowledge outside community pharmacy 
settings 
19% 1.99 
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Table 5: Perceived barriers to the provision of pharmaceutical care (N = 100) 
 




1. Lack of physical space for pharmaceutical care provision 79% 3.85 
2. The slow introduction of pharmacists’ law 66% 3.89 
3. Lack of patient acceptance of pharmaceutical care 71% 3.88 
4. Lack of time to provide pharmaceutical care 76% 3.88 
5. Lack of face-to-face communication with patient 55% 3.42 
6. Lack of effective communication skills 36% 2.97 
7. Lack of knowledge about drug use 29% 2.72 
8. Lack of compensation for pharmaceutical care provision 68% 3.87 
9. Insufficient communication with physician 92% 4.31 
10. Lack of support to pharmaceutical care from pharmacy 
owners 
37% 3.40 






A typical pharmacist in Macao would most likely 
be a young female, who held a bachelor degree 
in Pharmacy and practised for only a few years, 
spending more than half of her working hours on 
duties unrelated to prescription medicines. The 
high response rate to the questionnaire (95.3 %) 
indicated a common interest in pharmaceutical 
care and younger pharmacists might imply a 
higher level of acceptance and understanding of 
the professional service [4]. Many of them also 
showed a satisfactory understanding of the 
overall concept of pharmaceutical care. 
Nevertheless, a low level of pharmaceutical care 
was also observed. Less than 75 % fully 
recognized the need to act proactively which 
might profoundly jeopardize the development of 
pharmaceutical care [17]. When performing 
pharmaceutical care, respondents spent a lot of 
time trying to identify DRPs for the patients but 
they hardly evaluated or even challenged 
doctors’ prescriptions. There was literally no 
documentation of pharmaceutical practice and 
health education was only confined to the 
pharmacy setting which could explain why the 
pharmaceutical care processes often ended after 
the pharmacists’ first encounter with their 
patients as shown in another study [20].  
 
More than 40 % of the respondents did not think 
that they could provide more comprehensive 
pharmaceutical care, indicating that there were 
challenges they were unable to resolve on their 
own. Similar to the result of previous studies, 
insufficient communication with physicians, lack 
of physical space, lack of time and lack of patient 
acceptance were reported to be the most 
important barriers by the respondents [4,9,21]. 
Lack of compensation mechanism for the 
service, lack of supportive policies and lack of 
time and opportunity to communicate with 
patients were also considered significant. Only 
58 % of the respondents thought all patients 
taking medicines would require pharmacists’ 
help, reflecting a low level of reliance by patients 
on pharmacists ’professional service. 
 
Taking into account other countries’ experiences, 
the delayed development of pharmaceutical care 
could be explained by a lack of supportive 
policies and/or standards of practice to clearly 
define and mandate the professional obligations 
in the provision of pharmaceutical care as part of 
their essential practice. Without the necessary 
legal framework, neither the pharmacists nor 
other health care professionals could fully 
comprehend the importance of the pharmacist 
profession and the pharmaceutical care. This in 
turn posed a negative impact on doctors’ 
acceptance of the service and willingness to 
communicate with pharmacists about patient’s 
medication and health records. Patients for the 
same reason would not be keen in disclosing 
their medicine use with pharmacists and 
expecting any intervention. At the same time, 
pharmacy owners would not be motivated to 
adjust the physical environment in the pharmacy 
to appropriately accommodate the provision of 
the service. At the moment, pharmacists rarely 
had a chance to provide the service 
comprehensively. Without sufficient opportunities 
to practice, collection of data demonstrating the 
benefits of the service would be difficult. Until the 
cost and benefit of pharmaceutical care service 
can be justified with solid evidence, there is no 
condition for negotiation of a compensation 
mechanism for such service. Without reasonable 
financial incentives, pharmacy owners would not 
be motivated to incorporate the service into their 
business and to make manpower arrangement to 
free pharmacists out, from day-to-day front of 
shop duties to become dedicated to professional 
services.  
 
Although lack of effective communication skills 
and lack of appropriate knowledge were not 
highly regarded as the major barriers by the 
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respondents, they were rated the major barriers 
in other studies [22-25]. In this study, either the 
pharmacists had enough communication skills 
and clinical knowledge or they did not have 
enough practice opportunity to realize their 
shortcomings and the impact thereof on the 
provision of pharmaceutical care. Nevertheless, 
this area should be examined further for 
reassurance. 
 
Limitations of the study 
 
The study has several limitations. The current 
study was developed based on a thorough 
literature review. The questionnaire design was 
based on the theoretical basis of studies alike 
carried out abroad which may not fully address 
the situations specific to Macao and undermine 
the associated uncertainties of the results. 
Another limitation is the relatively small sample 
size of 100. Although it is proportionally 
significant given the Macao pharmacist workforce 
of 381, the sample size may not be sufficient to 
minimize bias and may prevent precise 
generalization of the results. This study did not 
take into account the effect of the pharmacy 
business mode which has been reported as an 
influential factor in some studies. Subgroup 
analyses between the different types of 
pharmacies using a large sample size may be 




Pharmacists in Macao have very positive attitude 
towards the provision of the service in the best 
interests of the patients and of the profession. 
However, there is a lack of responsibility to act 
proactively to provide the service and only some 
aspects of pharmaceutical care are currently 
conducted in their daily practice. Similar to 
findings in other studies, multiple perceived 
barriers are revealed, including insufficient 
communication with physicians, lack of working 
space, lack of time and lack of patient 
acceptance as the major ones. In the context of 
pharmacy practice situation in Macao, 
implementation of supportive policies and 
collection of evidence to demonstrate the 
benefits of pharmaceutical care are considered 
the foremost steps to alleviate the barriers for the 
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